Loading...
  • deafness
  • The Food and Drug Administration (FDA) has cleared for marketing the bone anchored hearing aid for individuals aged 5 years and older who have conductive or mixed hearing loss and for patients with sensorineural deafness in one ear and normal hearing in the other based on a 510(k) application. (wellmark.com)
  • Lin LM, Bowditch S, Anderson MJ, May B, Cox KM, Niparko K. Amplification in the rehabilitation of unilateral deafness: speech in noise and directional hearing effects with bone-anchored hearing and contralateral routing of signal amplification. (cochlear.com)
  • substantially
  • A removable adhesive anchor secures an external component of the bone conducting hearing device to the user and provides reliable connecting that is comfortable, such as by a substantially uniform force generation over the contact area between the device and the user. (google.com)